Cronin Chiropractic & Acupuncture Clinic is categorized under Chiropractors in Stokesdale, NC and active since 2007.
Cronin Chiropractic & Acupuncture Clinic was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Chiropractors business, which does work in the B2C market, and is classified as a Chiropractors, under code number 621310 by the NAICS.
If you are seeking more information, feel free to contact Dennis Cronin at the company’s single location by writing to 8410 Us Highway 158, Stokesdale, North Carolina NC 27357 or by phoning (763) 477-4545. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Cronin Chiropractic & Acupuncture Clinic |
Contact Person: | Dennis Cronin |
Address: | 8410 Us Highway 158, Stokesdale, North Carolina 27357 |
Phone Number: | (763) 477-4545 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2007 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Chiropractors |
SIC Code: | 8041 |
NAICS Code: | 621310 |
Share This Business: |
Cronin Chiropractic & Acupuncture Clinic was started in 2007 to provide professional Chiropractors under the SIC code 8041 and NAICS code 621310. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Dennis Cronin for inquiries that concern Cronin Chiropractic & Acupuncture Clinic by calling the company number (763) 477-4545, as your correspondence is most welcome. Additionally, the physical location of the single location of Cronin Chiropractic & Acupuncture Clinic can be found at the coordinates as well as the street address 8410 Us Highway 158 in Stokesdale, North Carolina 27357.
For its online presence, you may visit Cronin Chiropractic & Acupuncture Clinic’s website at and engage with its social media outlets through on Twitter and on Facebook.